Liang X - Search Results

1

Safety, tolerability, and pharmacokinetics/pharmacodynamics of JMT103 in patients with bone metastases from solid tumors.

Liang X, Xue J, Ge X, Li J, Li H, Xue L, Di L, Tang W, Song G, Li Q, Jiang H, Zhao W, Lin F, Shao B, Yang X, Wu Z, Zhang T, Wang C, Guo Y. Liang X, et al. Front Oncol. 2022 Aug 5;12:971594. doi: 10.3389/fonc.2022.971594. eCollection 2022. Front Oncol. 2022. PMID: 35992822 Free PMC article.

2

Non-genetic risk factors and predicting efficacy for docetaxel--drug-induced liver injury among metastatic breast cancer patients.

Wang Z, Liang X, Yu J, Zheng X, Zhu Y, Yan Y, Dong N, Di L, Song G, Zhou X, Wang X, Yang H, Ren J, Lyerly HK. Wang Z, et al. Among authors: liang x. J Gastroenterol Hepatol. 2012 Aug;27(8):1348-52. doi: 10.1111/j.1440-1746.2012.07131.x. J Gastroenterol Hepatol. 2012. PMID: 22432938

3

Specific genetic polymorphisms of IL10-592 AA and IL10-819 TT genotypes lead to the key role for inducing docetaxel-induced liver injury in breast cancer patients.

Liang X, Zhang J, Zhu Y, Lu Y, Zhou X, Wang Z, Yu J, Yan Y, Di L, Che L, Jiang H, Shao B, Wang X, Yang H, Lyerly HK, Ren J. Liang X, et al. Clin Transl Oncol. 2013 Apr;15(4):331-4. doi: 10.1007/s12094-012-0936-6. Epub 2012 Nov 10. Clin Transl Oncol. 2013. PMID: 23143946

4

HER2-specific T lymphocytes kill both trastuzumab-resistant and trastuzumab-sensitive breast cell lines in vitro.

Lin XL, Wang XL, Ma B, Jia J, Yan Y, Di LJ, Yuan YH, Wan FL, Lu YL, Liang X, Shen T, Ren J. Lin XL, et al. Among authors: liang x. Chin J Cancer Res. 2012 Jun;24(2):143-50. doi: 10.1007/s11670-012-0143-6. Chin J Cancer Res. 2012. PMID: 23357961 Free PMC article.

5

Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences.

Ren J, Di L, Song G, Yu J, Jia J, Zhu Y, Yan Y, Jiang H, Liang X, Che L, Zhang J, Wan F, Wang X, Zhou X, Lyerly HK. Ren J, et al. Among authors: liang x. Clin Transl Oncol. 2013 Oct;15(10):780-8. doi: 10.1007/s12094-013-1001-9. Epub 2013 Jan 29. Clin Transl Oncol. 2013. PMID: 23359185 Clinical Trial.

6

Mobilization of Peripheral Blood Stem Cells Using Regimen Combining Docetaxel with Granulocyte Colony-stimulating Factor in Breast Cancer Patients.

Yu J, Ren J, Di LJ, Song GH, Zhu YL, Zhang J, Liang X, Che L, Jiang HF, Jia J, Zhang CR. Yu J, et al. Among authors: liang x. Chin J Cancer Res. 2011 Mar;23(1):49-53. doi: 10.1007/s11670-011-0049-8. Chin J Cancer Res. 2011. PMID: 23467566 Free PMC article.

7

Capecitabine maintenance therapy for XT chemotherapy-sensitive patients with metastatic triple-negative breast cancer.

Liang X, Di L, Song G, Yan Y, Wang C, Jiang H, Li H. Liang X, et al. Chin J Cancer Res. 2014 Oct;26(5):550-7. doi: 10.3978/j.issn.1000-9604.2014.10.02. Chin J Cancer Res. 2014. PMID: 25400420 Free PMC article.

8

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients.

Liang X, Yan Y, Wang L, Song G, DI L, Jiang H, Wang C, Li H. Liang X, et al. Oncol Lett. 2015 Feb;9(2):987-993. doi: 10.3892/ol.2014.2787. Epub 2014 Dec 10. Oncol Lett. 2015. PMID: 25621076 Free PMC article.

9

[Predictive and prognostic value of monitoring lymphocyte subsets in peripheral blood before and after chemotherapy in patients with metastatic breast cancer].

Shao B, Li HP, DI LJ, Song GH, Jiang HF, Liang X, Wang CY, Yan Y, Lin XL, Wang LN, Wan FL, Yuan YH, You MN. Shao B, et al. Among authors: liang x. Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Apr 18;48(2):304-9. Beijing Da Xue Xue Bao Yi Xue Ban. 2016. PMID: 27080286 Free article. Chinese.

10

Efficacy and safety of trastuzumab combined with chemotherapy for first-line treatment and beyond progression of HER2-overexpressing advanced breast cancer.

Li H, Shao B, Yan Y, Song G, Liu X, Wang J, Liang X. Li H, et al. Among authors: liang x. Chin J Cancer Res. 2016 Jun;28(3):330-8. doi: 10.21147/j.issn.1000-9604.2016.03.07. Chin J Cancer Res. 2016. PMID: 27478318 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,786 results

Search Page

Filters